drugset / Trial / NCT00988988

The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections

NCT00988988 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Participants with multiple sclerosis that are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site will be recruited to examine histamine response of three topical treatments to reduce these symptoms.

Timeline

Start
2010-02
Primary completion
2012-08-03
Completion
2012-08-03

Outcome

Outcome not reported

Stopped: “Not approved by IRB”

Drugs

EvaluationDrugModalityDoseRoute
Comparator AGEE Unknown — Topical

Indications